Davis Capital Management
Source: SEC Form 13F · as of Mar 2026Davis Capital Management holds 28 biotech & pharma companies tracked by BioSniper, totaling $6.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
28
Total value held
$6.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 10,184 | $2.5M |
| AMGNAMGEN INC | 6,597 | $2.3M |
| ABBVAbbVie Inc. | 5,326 | $1.2M |
| MCKMcKesson Corporation | 223 | $193K |
| PMPhilip Morris International Inc | 435 | $72K |
| ABTABBOTT LABORATORIES | 429 | $44K |
| ELVElevance Health Inc. | 43 | $13K |
| LLYELI LILLY & Co | 13 | $12K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 42 | $11K |
| ALKSAlkermes plc. | 203 | $7K |
| MRKMerck & Co., Inc. | 21 | $3K |
| GILDGILEAD SCIENCES, INC. | 11 | $2K |
| PFEPFIZER INC | 50 | $1K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 3 | $1K |
| BMYBRISTOL MYERS SQUIBB CO | 19 | $1K |
| CORCencora Inc. | 3 | $942 |
| REGNREGENERON PHARMACEUTICALS, INC. | 1 | $773 |
| IQVIQVIA Holdings Inc. | 4 | $682 |
| GMOptec International, Inc. | 7 | $522 |
| CAHCardinal Health Inc. | 2 | $423 |
| BIIBBIOGEN INC. | 2 | $367 |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1 | $331 |
| INSMINSMED Inc | 2 | $327 |
| WSTWest Pharmaceutical Services Inc. | 1 | $251 |
| DGXQuest Diagnostics Incorporated | 1 | $196 |
| ZBHZimmer Biomet Holdings Inc. | 2 | $181 |
| MRNAModerna, Inc. | 1 | $51 |
| RPRXRoyalty Pharma plc | 1 | $48 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.